Medigard Ltd  

(Public, ASX:MGZ)   Watch this stock  
Find more results for MGZ
0.075
0.000 (0.00%)
Jul 3 - Close
ASX data delayed by 20 mins - Disclaimer
Currency in AUD
Range     -
52 week 0.01 - 0.14
Open     -
Vol / Avg. 0.00/1,667.00
Mkt cap 6.83M
P/E     -
Div/yield     -
EPS 0.00
Shares 91.01M
Beta     -
Inst. own     -

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin -29634.43% -29976.15%
Operating margin -23800.00% -29426.61%
EBITD margin - -26977.06%
Return on average assets -252.71% -167.23%
Return on average equity - -499.34%
CDP Score - -

Address

LEVEL 5 HQ Suite 52, 58 RIVERWALK AVENUE, ROBINA
GOLD COAST, QLD 4226
Australia
+61-7-55787822 (Phone)
+61-7-55787955 (Fax)

Website links

Description

Medigard Limited is an Australia-based medical devices company, engaged in the development of medical instruments. The Company's products include Auto-retractable Syringe, Manual Retractable Syringe, Blood Collection Device and Flash Back Needle. The Medigard vacuum Retractable Syringe operates as a normal syringe, but automatically retracts the needle from the body using the vacuum in the plunger to draw the needle back. The Manual Retractable Syringe’s plunger connects with the Luer and pulls the needle back inside the barrel of the syringe. The plunger can then be snapped off while the Luer and needle are firmly locked inside the barrel. The Medigard Blood Collection Device (BCD) features inventive vacuum technology to capture the needle after blood has been collected. Its Flash Back Needle is a complementary product for BCD. Flash back needles allow healthcare workers immediate visual confirmation of a successful venipuncture.

Officers and directors

Patricia Mary Boero Chief Financial Officer, Company Secretary
Donald Julian Channer Non-Executive Chairman of the Board
Robert Stephen Krakowiak Director
Christopher Jan Bishop Ph.D. Independent Non-Executive Director